Back

Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized controlled trial

26 August 2017 (13:55 - 14:08)
Organised by:
Congress Presentation Part of: Late-Breaking Science in PCI 1 Invasive and functional coronary imaging ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Myeong-Ki Hong

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

6 More presentations in this session

Presentation thumbnail
Comparison of titanium-nitride-oxide-coated versus everolimus-eluting stents in acute coronary syndrome
Doctor P. Tonino (Eindhoven, NL)
Slides Video
Presentation thumbnail
A Multicenter, Randomized-Controlled, Blinded Trial of Drug-Eluting vs. Bare Metal Stents in De Novo Saphenous Vein Graft Lesions
Mr E. Brilakis (Minneapolis, US)
Slides Video
Presentation thumbnail
Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention and Survival in Patients with Type 1 Diabetes Mellitus
Doctor M. Holzmann (Stockholm, SE)
Slides Video
Presentation thumbnail
Five-year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer
Doctor M. Natsuaki (Saga, JP)
Slides Video
Presentation thumbnail
Clinical outcomes of State-of-the-Art percutaneous coronary revascularization in patients with de novo three vessel disease: Results of the SYNTAX II trial.
Professor J. Escaned (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Science in PCI 1

The Event

Event poster

ESC Congress 2017

26 August 2017 13:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources